| Authors: |
Mattei J; Department of Hematology Oncology, UT Health Science Center San Antonio, San Antonio., Ruitao L; Department of Biostatistics., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wong MK; Department of Hematology Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Haydu LE; Department of Biostatistics., Patel SP; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tawbi H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Burton EM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. |